284 related articles for article (PubMed ID: 25020163)
61. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
62. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
63. Prevention of recurrent urinary tract infections in women.
Drug Ther Bull; 2013 Jun; 51(6):69-72. PubMed ID: 23766394
[TBL] [Abstract][Full Text] [Related]
64. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
[TBL] [Abstract][Full Text] [Related]
65. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Raz R; Stamm WE
N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
[TBL] [Abstract][Full Text] [Related]
66. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
[TBL] [Abstract][Full Text] [Related]
67. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
[TBL] [Abstract][Full Text] [Related]
68. [Effect of urinary tract infections in children with chronic renal failure on peritoneal dialysis].
Szczepańska M; Szprynger K; Adamczyk P
Pol Merkur Lekarski; 2004 Mar; 16(93):223-7. PubMed ID: 15190595
[TBL] [Abstract][Full Text] [Related]
69. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
70. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
Khan AU; Musharraf A
Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
[TBL] [Abstract][Full Text] [Related]
71. [Primary and secondary prevention of urinary tract infections].
Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Naber KG; Piechota HJ
Urologe A; 2011 Oct; 50(10):1248, 1250-2, 1254-6. PubMed ID: 21927878
[TBL] [Abstract][Full Text] [Related]
72. Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.
De Nisco NJ; Neugent M; Mull J; Chen L; Kuprasertkul A; de Souza Santos M; Palmer KL; Zimmern P; Orth K
J Mol Biol; 2019 Oct; 431(21):4368-4379. PubMed ID: 31002774
[TBL] [Abstract][Full Text] [Related]
73. Analysis of the Efficacy of a Sublingual Bacterial Vaccine in the Prophylaxis of Recurrent Urinary Tract Infection.
Carrión-López P; Martínez-Ruiz J; Librán-García L; Giménez-Bachs JM; Pastor-Navarro H; Salinas-Sánchez AS
Urol Int; 2020; 104(3-4):293-300. PubMed ID: 31962327
[TBL] [Abstract][Full Text] [Related]
74. Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis.
Madden-Fuentes RJ; Arshad M; Ross SS; Seed PC
Clin Ther; 2015 Sep; 37(9):2143-7. PubMed ID: 26233470
[TBL] [Abstract][Full Text] [Related]
75. Urinary Tract Infections After Urogynecologic Surgery: Risk Factors, Timeline, and Uropathogens.
Jung CE; Chen LH; Brubaker LT; Menefee SA
Urogynecology (Phila); 2023 Jul; 29(7):632-640. PubMed ID: 36701315
[TBL] [Abstract][Full Text] [Related]
76. Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children.
Khan A; Jhaveri R; Seed PC; Arshad M
J Pediatric Infect Dis Soc; 2019 May; 8(2):152-159. PubMed ID: 30053044
[TBL] [Abstract][Full Text] [Related]
77. The effect of intravesical instillations with Hyaluronic Acid on sexual dysfunction in women with recurrent urinary tract infections (RUTI).
Nightingale G; Shehab Q; Kandiah C; Rush L; Rowe-Jones C; Phillips CH
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():105-108. PubMed ID: 29277046
[TBL] [Abstract][Full Text] [Related]
78. [Recurrent urinary tract infections: prevention of recurrence with intravesical instillations of chondroitin sulfate and hyaluronic acid.].
Tornero Ruiz JI; Martínez Gómez G; Escudero Bregante JF; Gómez Gómez GA
Arch Esp Urol; 2017 Mar; 70(2):288-293. PubMed ID: 28300032
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women.
Fox KA; Lokken EM; Reed SD; Rahn DD
Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539
[TBL] [Abstract][Full Text] [Related]
80. Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference.
Cai T; Tamanini I; Collini L; Brugnolli A; Migno S; Mereu L; Tateo S; Pilatz A; Rizzo M; Liguori G; Bonkat G; Wagenlehner FME; Bjerklund Johansen TE
Eur Urol Focus; 2022 Sep; 8(5):1476-1482. PubMed ID: 35135727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
